Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

Go back to Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

Dermira (DERM) Misses Q1 EPS by 4c

May 22, 2023 4:12 PM EDT

Dermira (NASDAQ: DERM) reported Q1 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $19.4 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

... More